| Definition of treatment goals for moderate to severe psoriasis: a European consensus U Mrowietz, K Kragballe, K Reich, P Spuls, CEM Griffiths, A Nast, J Franke, ... Archives of dermatological research 303, 1-10, 2011 | 1128 | 2011 |
| Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs HP Kim, I Mani, L Iversen, VA Ziboh Prostaglandins, leukotrienes and essential fatty acids 58 (1), 17-24, 1998 | 799 | 1998 |
| Characterization of the interleukin‐17 isoforms and receptors in lesional psoriatic skin C Johansen, PA Usher, RB Kjellerup, D Lundsgaard, L Iversen, ... British Journal of Dermatology 160 (2), 319-324, 2009 | 449 | 2009 |
| The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling O Ananieva, J Darragh, C Johansen, JM Carr, J McIlrath, JM Park, ... Nature immunology 9 (9), 1028-1036, 2008 | 393 | 2008 |
| Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris R Gniadecki, B Bang, LE Bryld, L Iversen, S Lasthein, L Skov British Journal of Dermatology 172 (1), 244-252, 2015 | 324 | 2015 |
| Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid M Westergaard, J Henningsen, I Kratchmarova, K Kristiansen, ... Journal of Investigative Dermatology 116 (5), 702-712, 2001 | 307 | 2001 |
| Old and new biological therapies for psoriasis K Rønholt, L Iversen International journal of molecular sciences 18 (11), 2297, 2017 | 285 | 2017 |
| Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma YH Kim, M Duvic, E Obitz, R Gniadecki, L Iversen, A Österborg, ... Blood, The Journal of the American Society of Hematology 109 (11), 4655-4662, 2007 | 253 | 2007 |
| The mitogen‐activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin C Johansen, K Kragballe, M Westergaard, J Henningsen, K Kristiansen, ... British Journal of Dermatology 152 (1), 37-42, 2005 | 233 | 2005 |
| Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study O Ahlehoff, L Skov, G Gislason, J Lindhardsen, SL Kristensen, L Iversen, ... Journal of internal medicine 273 (2), 197-204, 2013 | 219 | 2013 |
| Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort O Ahlehoff, L Skov, G Gislason, R Gniadecki, L Iversen, LE Bryld, ... Journal of the European Academy of Dermatology and Venereology 29 (6), 1128-1134, 2015 | 211 | 2015 |
| Work environment factors, health, lifestyle and marital status as predictors of job change and early retirement in physically heavy occupations T Lund, L Iversen, KB Poulsen American journal of industrial medicine 40 (2), 161-169, 2001 | 211 | 2001 |
| H-Ras forms dimers on membrane surfaces via a protein–protein interface WC Lin, L Iversen, HL Tu, C Rhodes, SM Christensen, JS Iwig, ... Proceedings of the National Academy of Sciences 111 (8), 2996-3001, 2014 | 178 | 2014 |
| Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2 C Johansen, AT Funding, K Otkjaer, K Kragballe, UB Jensen, M Madsen, ... The Journal of Immunology 176 (3), 1431-1438, 2006 | 172 | 2006 |
| Auscultation in mild mitral regurgitation in dogs: observer variation, effects of physical maneuvers, and agreement with color Doppler echocardiography and phonocardiography HD Pedersen, J Häggström, T Falk, T Mow, LH Olsen, L Iversen, ... Journal of veterinary internal medicine 13 (1), 56-64, 1999 | 168 | 1999 |
| Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics L Iversen, HL Tu, WC Lin, SM Christensen, SM Abel, J Iwig, HJ Wu, ... Science 345 (6192), 50-54, 2014 | 157 | 2014 |
| Tofacitinib withdrawal and retreatment in moderate‐to‐severe chronic plaque psoriasis: a randomized controlled trial R Bissonnette, L Iversen, H Sofen, CEM Griffiths, P Foley, R Romiti, ... British Journal of Dermatology 172 (5), 1395-1406, 2015 | 153 | 2015 |
| Expression and localization of peroxisome proliferator-activated receptors and nuclear factor κB in normal and lesional psoriatic skin M Westergaard, J Henningsen, S Rasmussen, K Kristiansen, C Johansen, ... Journal of Investigative Dermatology 121 (5), 1104-1117, 2003 | 152 | 2003 |
| Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover T Krejsgaard, LM Lindahl, NP Mongan, MA Wasik, IV Litvinov, L Iversen, ... Seminars in immunopathology 39, 269-282, 2017 | 150 | 2017 |
| Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2 … K Reich, RB Warren, L Iversen, L Puig, I Pau‐Charles, A Igarashi, ... British Journal of Dermatology 182 (3), 605-617, 2020 | 143 | 2020 |
